Identification and evaluation of Nordihydroguaiaretic acid (NDGA) as an active traditional Chinese medicine compound inhibiting the 3C-like protease of feline infectious peritonitis virus
Authors:
- 16 September 2025
- journal article
- Published by Elsevier in Veterinary Microbiology
- Vol. 310, 110730
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2024YFD1800203)
- China Agricultural University (00109015)
- National Natural Science Foundation of China (32100156)
This publication has 25 references indexed in Scilit:
- Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitisJournal of Hepatology, 2025
- The S2 Pocket Governs the Genus‐Specific Substrate Selectivity of Coronavirus 3C‐Like ProteaseAdvanced Science, 2024
- Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assaysActa Pharmaceutica Sinica B, 2021
- Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) proteaseComputational Biology and Chemistry, 2020
- The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studiesVeterinary Microbiology, 2018
- The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infectionAntiviral Research, 2017
- Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infectionVirus Research, 2015
- Identification and characterisation of small molecule inhibitors of feline coronavirus replicationVeterinary Microbiology, 2014
- An update on feline infectious peritonitis: Diagnostics and therapeuticsThe Veterinary Journal, 2014
- Prooxidant activity and toxicity of nordihydroguaiaretic acid in clone-9 rat hepatocyte culturesFood and Chemical Toxicology, 2006